| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.004 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.006 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.12 | 0.006 |